deflazacort has been researched along with Insulin Sensitivity in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jefferies, JL; McMahon, MA; Rutter, MM; Rybalsky, I; Sawnani, H; Shellenbarger, KC; Tian, C; Wong, BL | 1 |
Bruno, A; Cavallo-Perin, P; Dall'Omo, AM; Imbimbo, B; Lombardi, A; Ozello, A; Pagano, G | 1 |
Benzi, L; Bruno, A; Calabrese, G; Di Ciani, G; Pagano, G; Passeri, A; Spallone, V | 1 |
1 trial(s) available for deflazacort and Insulin Sensitivity
Article | Year |
---|---|
Change in glucose metabolism after long-term treatment with deflazacort and betamethasone.
Topics: Administration, Oral; Anti-Inflammatory Agents; Betamethasone; Blood Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Pregnenediones; Time Factors | 1992 |
2 other study(ies) available for deflazacort and Insulin Sensitivity
Article | Year |
---|---|
Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
Topics: Adolescent; Age Factors; Child; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Exercise Therapy; Follow-Up Studies; Fractures, Bone; Glucocorticoids; Humans; Insulin Resistance; Long-Term Care; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Patient Care Team; Prednisone; Pregnenediones; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Weight Gain | 2017 |
Deflazacort versus prednisone diabetogenic effect evaluated by glucose clamp and compartmental analysis.
Topics: Adult; Blood Glucose; Humans; Insulin; Insulin Resistance; Insulin Secretion; Kinetics; Male; Prednisone; Pregnenediones | 1984 |